Updates
Added by St.2020, c.260, § 47, for contracts that take effect or are renewed on or after January 1, 2022.
Section 47NN
Any policy, contract, agreement, plan or certificate of insurance issued, delivered or renewed within or without the commonwealth shall provide coverage for treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute-onset neuropsychiatric syndrome including, but not limited to, the use of intravenous immunoglobulin therapy.
Contact for Mass. General Laws c.175 § 47NN
Online
Last updated: | January 1, 2021 |
---|